Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making.
Dig Dis. 2023;41(6):879-889. doi: 10.1159/000531789. Epub 2023 Aug 23.
Dig Dis. 2023.
PMID: 37611561
[To consider negative viral loads below the limit of quantification can lead to errors in the diagnosis and treatment of hepatitis C virus infection].
Acero Fernández D, Ferri Iglesias MJ, López Nuñez C, Louvrie Freire R, Aldeguer Manté X.
Acero Fernández D, et al. Among authors: aldeguer mante x.
Gastroenterol Hepatol. 2013 Aug-Sep;36(7):443-9. doi: 10.1016/j.gastrohep.2013.04.006. Epub 2013 Jul 9.
Gastroenterol Hepatol. 2013.
PMID: 23849764
Spanish.
Item in Clipboard
Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years.
Acero Fernández D, Ferri Iglesias MJ, Buxó Pujolràs M, López Nuñez C, Serra Matamala I, Queralt Molés X, Aldeguer Manté X.
Acero Fernández D, et al. Among authors: aldeguer mante x.
Gastroenterol Hepatol. 2018 Jan;41(1):2-11. doi: 10.1016/j.gastrohep.2017.09.004. Epub 2017 Nov 14.
Gastroenterol Hepatol. 2018.
PMID: 29150360
English, Spanish.
Item in Clipboard
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group.
D'Haens G, et al.
N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940.
N Engl J Med. 2023.
PMID: 37379135
Clinical Trial.
Item in Clipboard
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group.
Peyrin-Biroulet L, et al.
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798039
Free article.
Clinical Trial.
Item in Clipboard
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Danese S, Colombel JF, Lukas M, Gisbert JP, D'Haens G, Hayee B, Panaccione R, Kim HS, Reinisch W, Tyrrell H, Oh YS, Tole S, Chai A, Chamberlain-James K, Tang MT, Schreiber S; GARDENIA Study Group.
Danese S, et al.
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):118-127. doi: 10.1016/S2468-1253(21)00294-6. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798038
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite